SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (882)4/13/2000 3:39:00 PM
From: BostonView  Respond to of 1321
 
QLTI to be featured on CNBC in a few minutes!

Thanks Ian, I'll check the Nesbitt stuff.

BV



To: Ian@SI who wrote (882)4/13/2000 3:40:00 PM
From: Ian@SI  Respond to of 1321
 
After this commercial break on CNBC, Joe Kernen is about to mention the FDA approval of Visudyne.

That's usually good for a nice pop. We're currently up 2 14 and rising quickly from up 1 just prior to the teaser.

now 2 5/8. and still going.

Thank you CNBC...

Ian.



To: Ian@SI who wrote (882)4/13/2000 3:42:00 PM
From: Scripts  Read Replies (1) | Respond to of 1321
 
Well we have finally been approved. I wonder how many went blind during the past few months??

I must say that I am disappointed by the price reaction. I had hoped to see a $20-30 rise once doubt was removed but the markets were against us.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News